How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
22/11/2021 - 9 minutes
Boehringer Ingelheim
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
11/05/2021 - 7 minutes
Boehringer Ingelheim Acquires Cancer Vaccine Biotech in €325M Deal
The German giant Boehringer Ingelheim has acquired the Swiss company AMAL Therapeutics and its cancer…
16/07/2019 - 2 minutes
Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company
Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian…
13/09/2018 - 2 minutes
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has…
05/04/2018 - 2 minutes
No Nonsense Boehringer Ingelheim Jettisons Failing Alzheimer’s Disease Drug
Boehringer Ingelheim has ditched its Alzheimer's drug after it failed to meet the endpoints of…
12/02/2018 - 3 minutes
Boehringer Ingelheim Doubles its Venture Fund for Exciting Biotech
Boehringer Ingelheim has committed to continue helping young companies grow by doubling the size of…
04/01/2018 - 2 minutes
Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner
Santa Claus is not the only busy one in the weeks leading up to Christmas…
19/12/2017 - 2 minutes
German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration
Boehringer Ingelheim's fight against liver disease is taking shape, having agreed on a partnership with…
08/11/2017 - 3 minutes
German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval
Cyltezo, an adalimumab biosimilar drug by Boehringer Ingelheim, has received the backing to be marketed…
18/09/2017 - 1 minute
French Biotech Lures Big Pharma with Fibrosis Treatments
This week, Inventiva has received a milestone payment from Boehringer Ingelheim and extended its collaboration with…
05/09/2017 - 1 minute
Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs
Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2…
23/08/2017 - 1 minute
